The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Identification of Ultrasound-Sensitive Prognostic Markers of LAML and Construction of Prognostic Risk Model Based on WGCNA

Lung cancer in patients who have never smoked — an emerging disease

AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research

Combinatorial tumor suppressor inactivation efficiently initiates lung adenocarcinoma with therapeutic vulnerabilities

Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma - ScienceDirect

IJMS, Free Full-Text

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

LTK fusions: A new target emerges in non-small cell lung cancer - ScienceDirect

CLIP1-LTK fusion: A novel druggable gene fusion in NSCLC, identified using LC-SCRUM-Asia genomic screening platform -A step further to precision medicine

Biomolecules, Free Full-Text

Frontiers Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer